19 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/boehringers-zongertinib-receives-priority-review-from-us-fda-for-the-treatment-of-her2-erbb2-mutant-advanced-non-small-cell-lung-cancer-302379614.html
19 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2025/02/19/3028657/0/en/Boehringer-s-zongertinib-receives-Priority-Review-from-U-S-FDA-for-the-treatment-of-HER2-ERBB2-mutant-advanced-non-small-cell-lung-cancer.html